Dentsply Sirona Q3 net loss $266M; lowers FY23 guidance; appoints Brian Gladden to board
DENTSPLY SIRONA Inc.
- Q3 net sales flat at $947M, organic sales -0.3%; GAAP net loss $266M ($1.25/share) including $302M impairment.
- Adjusted EPS $0.49, up 19.6% YoY; adjusted EBITDA margin 18.2% vs 17.5% a year ago.
- FY23 guidance lowered: organic sales growth to ~1% from ~3%; adjusted EPS to $1.80–$1.85 from $1.92–$2.02.
- Brian Gladden appointed to Board effective Jan 1, 2024, replacing retiring director Harry Kraemer Jr.
- Company plans $150M share repurchase in Q4 2023.